Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysis.

Literature DB >> 23300360

Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysis.

J Younus¹, T Vandenberg, M Jawaid, M A Jawaid.

Abstract

Entities: Chemical Disease

Keywords: Febrile neutropenia; adjuvant chemotherapy; breast cancer

Year: 2012 PMID： 23300360 PMCID： PMC3503667 DOI： 10.3747/co.19.1174

Source DB: PubMed Journal: Curr Oncol ISSN： 1198-0052 Impact factor: 3.677

× No keyword cloud information.

10 in total

1. Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-a retrospective analysis.

Authors: T Vandenberg; J Younus; S Al-Khayyat
Journal: Curr Oncol Date: 2010-04 Impact factor: 3.677

2. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Authors: Thomas J Smith; James Khatcheressian; Gary H Lyman; Howard Ozer; James O Armitage; Lodovico Balducci; Charles L Bennett; Scott B Cantor; Jeffrey Crawford; Scott J Cross; George Demetri; Christopher E Desch; Philip A Pizzo; Charles A Schiffer; Lee Schwartzberg; Mark R Somerfield; George Somlo; James C Wade; James L Wade; Rodger J Winn; Antoinette J Wozniak; Antonio C Wolff
Journal: J Clin Oncol Date: 2006-05-08 Impact factor: 44.544

3. Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey.

Authors: S Verma; L Provencher; R Dent
Journal: Curr Oncol Date: 2011-08 Impact factor: 3.677

4. Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.

Authors: Stephen E Jones; Michael A Savin; Frankie Ann Holmes; Joyce A O'Shaughnessy; Joanne L Blum; Svetislava Vukelja; Kristi J McIntyre; John E Pippen; James H Bordelon; Robert Kirby; John Sandbach; William J Hyman; Pankaj Khandelwal; Angel G Negron; Donald A Richards; Stephen P Anthony; Robert G Mennel; Kristi A Boehm; Walter G Meyer; Lina Asmar
Journal: J Clin Oncol Date: 2006-12-01 Impact factor: 44.544

5. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

Authors: Hyman B Muss; Susan Woolf; Donald Berry; Constance Cirrincione; Raymond B Weiss; Daniel Budman; William C Wood; I Craig Henderson; Clifford Hudis; Eric Winer; Harvey Cohen; Judith Wheeler; Larry Norton
Journal: JAMA Date: 2005-03-02 Impact factor: 56.272

6. Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection.

Authors: Lillian Sung; Paul C Nathan; Shabbir M H Alibhai; George A Tomlinson; Joseph Beyene
Journal: Ann Intern Med Date: 2007-09-18 Impact factor: 25.391

7. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials.

Authors: Michele De Laurentiis; Giuseppe Cancello; Diego D'Agostino; Mario Giuliano; Antonio Giordano; Emilia Montagna; Rossella Lauria; Valeria Forestieri; Angela Esposito; Lucrezia Silvestro; Roberta Pennacchio; Carmen Criscitiello; Agnese Montanino; Gennaro Limite; Angelo Raffaele Bianco; Sabino De Placido
Journal: J Clin Oncol Date: 2008-01-01 Impact factor: 44.544

8. Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.

Authors: Stephen Jones; Frankie Ann Holmes; Joyce O'Shaughnessy; Joanne L Blum; Svetislava J Vukelja; Kristi J McIntyre; John E Pippen; James H Bordelon; Robert L Kirby; John Sandbach; William J Hyman; Donald A Richards; Robert G Mennel; Kristi A Boehm; Wally G Meyer; Lina Asmar; Daniel Mackey; Stefan Riedel; Hyman Muss; Michael A Savin
Journal: J Clin Oncol Date: 2009-02-09 Impact factor: 44.544

9. Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer.

Authors: Tomasz P Srokowski; Shenying Fang; Gabriel N Hortobagyi; Sharon H Giordano
Journal: J Clin Oncol Date: 2009-03-23 Impact factor: 44.544

Review 10. Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.

Authors: M Clarke; A S Coates; S C Darby; C Davies; R D Gelber; J Godwin; A Goldhirsch; R Gray; R Peto; K I Pritchard; W C Wood
Journal: Lancet Date: 2008-01-05 Impact factor: 79.321